Nasdaq · CIK 0001759425
MIRM Mirum Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing 6 d ago. Close $86.01 on Oct 9, 2026, +34% from the 52-week low and -33% from the high.
Last 90 days
Net insider value
-$4.0M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$4.0M by 3 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
MIRMOct 9, 2026 · close 86.01
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Mirum Pharmaceuticals, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Eric Bjerkholt CHIEF FINANCIAL OFFICER sell | $978k 9,943 shares | -18% | - | |
| 38Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $66k 658 shares | -52% | - | |
| 35Weak | Christopher Peetz CHIEF EXECUTIVE OFFICER sell | $3.0M 30,000 shares | -13% | - | |
| 46Moderate | William Fairey director sell | $155k 3,203 shares | -56% | +28% from low-9% from high | |
| 15Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $107k 2,415 shares | -50% | - | |
| 15Weak | Patrick J Heron director buy | $24k 549 shares | +0% | - | |
| 25Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $2.6M 57,606 shares | -603% | - | |
| 30Weak | Patrick J Heron director buy | $100k 2,298 shares | +1% | - | |
| 29Weak | Patrick J Heron director buy | $84k 1,915 shares | +1% | - | |
| 18Weak | Patrick J Heron director buy | $73k 1,602 shares | +1% | - | |
| 12Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $51k 1,064 shares | -20% | - | |
| 11Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $43k 902 shares | -20% | - | |
| 10Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $32k 750 shares | -20% | - | |
| 30Weak | Jolanda Howe SVP, GLOBAL CONTROLLER sell | $118k 2,500 shares | -51% | - |
Transactions
The last 74 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +5,305 | $19.19 | $102k | 199,745 | 6 d ago |
| Oct 6, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +6,892 | $15.87 | $109k | 206,637 | 6 d ago |
| Oct 6, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Employee Stock Option (right to buy)derivative | -5,305 | $0.00 | $0 | 169,695 | 6 d ago |
| Oct 6, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Employee Stock Option (right to buy)derivative | -6,892 | $0.00 | $0 | 233,108 | 6 d ago |
| Sep 11, 2026 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +18,333 | - | - | 54,688 | 27 d ago |
| Sep 14, 2026 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -9,943 | $98.37 | $978k | 44,745 | 27 d ago |
| Sep 11, 2026 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -18,333 | $0.00 | $0 | 0 | 27 d ago |
| Sep 2, 2026 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -658 | $100.00 | $66k | 616 | 39 d ago |
| Sep 1, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock10b5-1 | +30,000 | $2.94 | $88k | 224,440 | 39 d ago |
| Sep 1, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock10b5-1 | -8,312 | $98.08 | $815k | 216,128 | 39 d ago |
| Sep 1, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock10b5-1 | -21,688 | $98.91 | $2.1M | 194,440 | 39 d ago |
| Sep 1, 2026 | Christopher Peetz CHIEF EXECUTIVE OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 58,487 | 39 d ago |
| Jun 11, 2025 | William Fairey director | SOpen-market sale Common Stock | -3,203 | $48.42 | $155k | 2,500 | Jun 13, 2025 |
| May 29, 2025 | Laura Brege director | MOption exercise Common Stock | +5,703 | - | - | 15,703 | Jun 2, 2025 |
| May 29, 2025 | Michael G Grey director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Lon Cardon director | MOption exercise Common Stock | +5,703 | - | - | 5,703 | Jun 2, 2025 |
| May 29, 2025 | Laurent Fischer director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Patrick J Heron director | MOption exercise Common Stock | +5,703 | - | - | 5,703 | Jun 2, 2025 |
| May 29, 2025 | William Fairey director | MOption exercise Common Stock | +5,703 | - | - | 5,703 | Jun 2, 2025 |
| May 29, 2025 | Laurent Fischer director | AGrant or award Restricted Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 29, 2025 | Michael G Grey director | AGrant or award Deferred Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 29, 2025 | William Fairey director | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Lon Cardon director | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | William Fairey director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Lon Cardon director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Patrick J Heron director | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | Lon Cardon director | AGrant or award Restricted Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 29, 2025 | William Fairey director | AGrant or award Deferred Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 29, 2025 | Laura Brege director | AGrant or award Deferred Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 29, 2025 | Patrick J Heron director | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | Patrick J Heron director | AGrant or award Deferred Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| Mar 18, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -2,415 | $44.45 | $107k | 2,426 | Mar 19, 2025 |
| Mar 14, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +528 | $44.11 | $23k | 168,651 | Mar 18, 2025 |
| Mar 15, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock10b5-1 | +5,315 | - | - | 9,547 | Mar 18, 2025 |
| Mar 17, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +21 | $43.93 | $923 | 168,672 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -2,900 | $44.21 | $128k | 6,647 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock10b5-1 | +52,900 | $2.94 | $156k | 59,547 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -50,111 | $44.33 | $2.2M | 9,436 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -2,789 | $44.75 | $125k | 6,647 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock10b5-1 | -1,806 | $44.36 | $80k | 4,841 | Mar 18, 2025 |
| Mar 15, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Performance Restricted Stock Unitsderivative10b5-1 | -5,315 | $0.00 | $0 | 2,658 | Mar 18, 2025 |
| Mar 17, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Stock Option (right to buy)derivative10b5-1 | -52,900 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Mar 10, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +758 | $42.66 | $32k | 166,583 | Mar 12, 2025 |
| Mar 10, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +577 | $43.37 | $25k | 167,160 | Mar 12, 2025 |
| Mar 11, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +963 | $43.77 | $42k | 168,123 | Mar 12, 2025 |
| Mar 6, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +1,335 | $43.89 | $59k | 165,245 | Mar 10, 2025 |
| Mar 7, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +580 | $43.21 | $25k | 165,825 | Mar 10, 2025 |
| Mar 4, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +1,279 | $45.55 | $58k | 163,587 | Mar 6, 2025 |
| Mar 4, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +56 | $45.96 | $2,574 | 163,643 | Mar 6, 2025 |
| Mar 5, 2025 | Patrick J Heron director | POpen-market purchase Common Stockindirect: By Frazier Life Sciences X, L.P. | +267 | $44.55 | $12k | 163,910 | Mar 6, 2025 |
| Jan 31, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock | +1,772 | - | - | 5,296 | Feb 4, 2025 |
| Feb 3, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock | -1,064 | $48.22 | $51k | 4,232 | Feb 4, 2025 |
| Jan 31, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Restricted Stock Unitsderivative | -1,772 | $0.00 | $0 | 1,771 | Feb 4, 2025 |
| Jan 23, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock | +1,500 | - | - | 4,426 | Jan 27, 2025 |
| Jan 23, 2025 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +2,667 | - | - | 35,946 | Jan 27, 2025 |
| Jan 23, 2025 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,667 | $0.00 | $0 | 5,333 | Jan 27, 2025 |
| Jan 24, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock | -902 | $47.92 | $43k | 3,524 | Jan 27, 2025 |
| Jan 23, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Restricted Stock Unitsderivative | -1,500 | $0.00 | $0 | 3,000 | Jan 27, 2025 |
| Jan 21, 2025 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 23, 2025 |
| Jan 21, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | AGrant or award Stock Option (right to buy)derivative | +18,500 | $0.00 | $0 | 18,500 | Jan 23, 2025 |
| Jan 21, 2025 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | AGrant or award Restricted Stock Unitsderivative | +10,000 | $0.00 | $0 | 10,000 | Jan 23, 2025 |
| Jan 21, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | AGrant or award Restricted Stock Unitsderivative | +4,625 | $0.00 | $0 | 4,625 | Jan 23, 2025 |
| Jan 21, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | AGrant or award Performance Restricted Stock Unitsderivative | +7,973 | $0.00 | $0 | 7,973 | Jan 23, 2025 |
| Jan 6, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock | +1,250 | - | - | 3,676 | Jan 8, 2025 |
| Jan 7, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock | -750 | $42.82 | $32k | 2,926 | Jan 8, 2025 |
| Jan 6, 2025 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Nov 14, 2024 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Common Stock | +2,500 | $2.94 | $7,350 | 4,926 | Nov 15, 2024 |
| Nov 14, 2024 | Jolanda Howe SVP, GLOBAL CONTROLLER | SOpen-market sale Common Stock | -2,500 | $47.10 | $118k | 2,426 | Nov 15, 2024 |
| Nov 14, 2024 | Jolanda Howe SVP, GLOBAL CONTROLLER | MOption exercise Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 52,900 | Nov 15, 2024 |
| Nov 8, 2024 | Eric Bjerkholt CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +475 | $21.05 | $9,997 | 33,279 | Nov 14, 2024 |
| Nov 8, 2024 | Christopher Peetz CHIEF EXECUTIVE OFFICER | AGrant or award Common Stock | +65 | $21.05 | $1,368 | 126,848 | Nov 14, 2024 |
| Nov 8, 2024 | Joanne Quan CHIEF MEDICAL OFFICER | AGrant or award Common Stock | +118 | $21.05 | $2,483 | 118 | Nov 14, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Eric BjerkholtCHIEF FINANCIAL OFFICER
- Laura Bregedirector
- Lon Cardondirector
- William Faireydirector
- Laurent Fischerceo, president, officer, director
- Michael G Greydirector
- Patrick J Herondirector, owner
- Jolanda HoweSVP, GLOBAL CONTROLLER
- Christopher PeetzCHIEF EXECUTIVE OFFICER
- Joanne QuanCHIEF MEDICAL OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.